A Study of Gene Xpert in Screening of Sputum in HIV Positive Patients Presenting to Tertiary Care Centre
Keywords:
Tuberculosis, MDR Tuberculosis, HIV, Gene XpertAbstract
Introduction: Present study was conducted to study Gene Xpert in screening of sputum in HIV positive patients, to estimate the burden of drug resistance TB in HIV patients and to estimate the prevalence of MDR TB in HIV positive patients.
Methods: RNTCP is currently using Gene Xpert to screen all HIV positive patients to diagnose pulmonary TB and rifampicin resistance. In this study, pulmonary samples referred to state level intermediate reference laboratories (IRLs) Indore between January 2015 to December 2015 were investigated and subjected to Gene Xpert.
Results: A total of 3033 pulmonary specimens were included in the study undergoing Gene Xpert; out of which 604 specimens were from HIV positive patients. In 85 (14.07%) HIV positive patients (out of 604) MTB was detected and RIF was sensitive (14.07%). In 06 (0.99%) HIV positive patients MTB, was detected and RIF resistance was found.
Conclusion: Screening of pulmonary samples with Gene Xpert in all HIV positive patients has enormous scope in early diagnosis and treatment of TB in terms of active case finding of patients with drug resistant tuberculosis. The results are available in less than 2 hours. This leads to less transmission of disease with reduced morbidity.
References
Global tuberculosis control report 2012. Available at: http://apps.who.int/iris/bitstream/10665/75938/1/9789241564502_eng.pdf. Accessed August 3rd, 2016
Global Tuberculosis Report 2014. Available at: http://apps.who.int/iris/bitstream/10665/137094/1/9789241564809_eng.pdf. Accessed August 3rd, 2016.
Xpert MTB/RIF Assay for the Diagnosis of Pulmonary and Extrapulmonary TB in Adults and Children: Policy Update. Geneva: World Health Organization;Issued date 2013. Available at: http://apps.who.int/iris/bitstream/10665/112472/1/9789241506335_eng.pdf. Accessed August 3rd, 2016.
Weyer K, Mirzayev F, Migliori GB, Gemert WV, D’Ambrosio L, Zignol M. Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF. European Respiratory Jour-nal.2013;42(1):252–71.
Barnes PF, Bloch AB, Davidson PT, et al. Current con-cepts: Tuberculosis in patients with human immunodefi-ciency virus infection. N Engl J Med. 1991;324(23):1644–1650.
Steingart KR, Ramsay A, Pai M. Optimizing sputum smear microscopy for the diagnosis of pulmonary tuber-culosis. Expert Rev Anti Infect Ther. 2007;5(3):327–331.
TB India 2014. RNTCP, Annual status report. Available at: http://www.tbcindia.nic.in. Accessed August 3rd, 2016.
Armand S., Vanhuls P., Delcroix G., Courcol R., Lemaître N. Comparison of the Xpert MTB/RIF test with an IS6110-TaqMan real-time PCR assay for direct detection of Mycobacterium tuberculosis in respiratory and non-respiratory specimens. J. Clin. Microbiol. 2011 49:1772–1776.
Moure R., et al. Rapid detection of Mycobacterium tuber-culosis complex and rifampin resistance in smear-negative clinical samples by use of an integrated real-time PCR method. J. Clin. Microbiol. 2011;49:1137–1139.
Raja S., et al. Technology for automated, rapid, and quantitative PCR or reverse transcription-PCR clinical testing. Clin. Chem. 2005;51:882–890.
Boehme C. C., et al. Rapid molecular detection of tuber-culosis and rifampin resistance. N. Engl. J. Med. 2010;363:1005–1015.
Marlowe E. M., et al. Evaluation of the Cepheid Xpert MTB/RIF assay for direct detection of Mycobacterium tuberculosis complex in respiratory specimens. J. Clin. Microbiol.2011;49(4):1621–1623.
Helb D., et al. Rapid detection of Mycobacterium tuber-culosis and rifampin resistance by use of on-demand, near-patient technology. J. Clin. Microbiol. 2010;48:229–237.
Avashia S, Choubey S, Mishra S, et al. To study the use-fulness of CBNAAT (Cartridge Based Nucleic Acid Am-plification Test) in BAL (Bronchoalveolar Lavage) sam-ples in the diagnosis of smear-negative/non-sputum producing patients with suspected tuberculosis. J Evolu-tion Med Dent Sci. 2016;5(1):55-59.
Avashia S, Bansal D, Ahuja K, et al. Comparison of con-ventional methods with gene xpert mtb/rif assay for rap-id detection of mycobacterium tuberculosis and rifam-picin resistance in extra pulmonary samples. Int J Med Res Rev 2016;4(2):181-185.
Ngyuyen T, et al. Evaluation of Gene Xpert MTB/RIF for Diagnosis of Tuberculous Meningitis. J Clin Microbiol. 2014;52(1):226-233
Rajasekaran S, Chandrasekar C. HIV coinfection among multidrug resistant and extensively drug resistant tuber-culosis patients – a trend. J Indian Med Assoc. 2009;107(5):281-6.
Deivanayagam C, Rajasekaran S. Prevalence of acquired MDR-TB and HIV co-infection. Indian J Chest Dis Alliled Sci. 2002;44(4):237-42.
Boehme C. C., et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug re-sistance: a multicentre implementation study. Lancet 2011;377:1495–1505.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The authors retain the copyright of their article, with first publication rights granted to Medsci Publications.
